SSAO的取代的3-鹵代烯丙基胺抑制劑及其用途

• 收藏
• 分享

专利权人:

Boehringer Ingelheim International GmbH;勃林格殷格翰國際有限公司

发明人:

DEODHAR, Mandar,FINDLAY, Alison, Dorothy,FOOT, Jonathan, Stuart,JAROLIMEK, Wolfgang,MCDONALD, Ian, Alexander,ROBERTSON, Alan,TURNER, Craig, Ivan,沃爾夫岡‧亞羅利梅克,MCDONALD, Ian, Alexander,I‧A‧麥克唐納,ROBERTSON,

申请号：

HK18104502.3

公开号：

HK1245237A

申请日:

2018.04.04

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

The application relates to substituted 3-haloallylamine derivatives of Formula I which act as SSAO/VAP-1 inhibitors. The compounds of Formula I, or pharmaceutically acceptable salts thereof, are useful for the treatment of inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/